Straumann Group reported a 6% increase in revenue to CHF 707 million in the second quarter, with organic growth accelerating to 8.5%. The Swiss dental implant and digital solutions provider attributed the performance to strong demand in implantology and its expanding portfolio of digital solutions.
For the first half of the year, Straumann posted a 2% rise in revenue to approximately CHF 1.4 billion, with organic growth remaining positive. The company did not provide a full-year revenue forecast update in the statement.
Straumann’s profitability improved alongside revenue growth, reflecting operational efficiencies and sustained pricing power in its core markets. The group’s focus on high-margin digital workflows and premium implant systems continues to support margins despite broader macroeconomic pressures in healthcare and manufacturing sectors.
The company’s results follow a period of steady expansion in the dental implant market, driven by aging populations and increasing adoption of digital dentistry. Straumann has maintained its leadership position in the sector, competing with peers such as Dentsply Sirona and Zimmer Biomet in the global dental solutions space.
Shares of Straumann have outperformed the broader Swiss market in 2025, reflecting investor confidence in its growth strategy and resilience amid economic uncertainty.
